AAOMS Annual Meeting

After a clinical trial showed the treatment was more effective than placebo, the FDA approved the first treatment for episodic cluster headache in adults that reduces the frequency of attacks.

After a clinical trial showed the treatment was more effective than placebo, the FDA approved the first treatment for episodic cluster headache in adults that reduces the frequency of attacks.

The FDA has issued a warning to women of childbearing age against the use of dietary supplements that contain vinpocetine, due to risk for adverse effects on the fetus, including miscarriage.

After a multinational, double-blind trial showed positive results, the FDA approved a new indication for an already-approved antibacterial drug.

After a multinational, double-blind trial showed positive results, the FDA approved a new indication for an already-approved antibacterial drug.

After a multinational, double-blind trial showed positive results, the FDA approved a new indication for an already-approved antibacterial drug.

The FDA has cleared new tests for the detection of antibodies to the Zika virus and the detection of chlamydia- and gonorrhea-causing bacteria from throat and rectum samples.

The US Food and Drug Administration has granted approval to a foam treatment for plaque psoriasis in adolescents.

The US Food and Drug Administration has granted approval to a foam treatment for plaque psoriasis in adolescents.

After a single trial of 38 pediatric patients showed promise, the FDA gave this treatment priority review in the approval process.